First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion

IntroductionBone and joint infections (BJIs) caused by multidrug-resistant bacteria are becoming more frequent. However, data on the use of novel β-lactam/β-lactamase inhibitors, such as imipenem/cilastatin/relebactam (I-R) and meropenem/vaborbactam (MVB), to treat BJIs is lacking. Furthermore, prol...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Paul Laffont-Lozes, Tayma Naciri, Alix Pantel, Aurélie Martin, Anne-Sophie Pruvot-Occean, Vincent Haignere, Paul Loubet, Albert Sotto, Romaric Larcher
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2024-10-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	bone and joint infection vertebral osteomyelitis meropenem/vaborbactam continuous infusion imipenem/cilastatin/relebactam extended infusion
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1347306/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!